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Abstract
Background: Cervical ripening is a prerequisite for a normal obstetrical outcome. This process, including labor,
is a painful event that shares features with inflammatory reactions where peripheral nociceptive pathways are
involved. The capsaicin and heat receptor TRPV1 is a key molecule in sensory nerves involved in peripheral
nociception, but little is known regarding its role in the pregnant uterus. Therefore, the aim of this study was to
investigate human corpus and cervix uteri during pregnancy and labor and non-pregnant controls for the presence
of TRPV1.
Methods: We have investigated human uterine corpus and cervix biopsies at term pregnancy and parturition.
Biopsies were taken from the upper edge of the hysterotomy during caesarean section at term (n = 8), in labor
(n = 8) and from the corresponding area in the non-pregnant uterus after hysterectomy (n = 8). Cervical biopsies
were obtained transvaginally from the anterior cervical lip. Serial frozen sections were examined
immunohistochemically using specific antibodies to TRPV1 and nerve markers (neurofilaments/peripherin).
Results: In cervix uteri, TRPV1-immunoreactive fibers were scattered throughout the stroma and around blood
vessels, and appeared more frequent in the sub-epithelium. Counts of TRPV1-immunoreactive nerve fibers were
not significantly different between the three groups. In contrast, few TRPV1-immunoreactive fibers were found
in nerve fascicles in the non-pregnant corpus, and none in the pregnant corpus.
Conclusion: In this study, TRPV1 innervation in human uterus during pregnancy and labor is shown for the first
time. During pregnancy and labor there was an almost complete disappearance of TRPV1 positive nerve fibers in
the corpus. However, cervical innervation remained throughout pregnancy and labor. The difference in TRPV1
innervation between the corpus and the cervix is thus very marked. Our data suggest that TRPV1 may be involved
in pain mechanisms associated with cervical ripening and labor. Furthermore, these data support the concept that
cervix uteri may be the major site from which labor pain emanates. Our findings also support the possibility of
developing alternative approaches to treat labor pain.
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Background
Giving birth is often very painful. Consequently, there is a
demand for easily accessible and effective relief of labor
pain. Various forms of central neuroaxial blockades
(CNB) are currently the most efficient methods to allevi-
ate labor pain and widely used in the "Developed
world"[1]. However, from a global point of view, very few
women have access to efficacious labor pain relief. This
reality challenged us to study nerve-related changes taking
place in corpus and cervix uteri during pregnancy and
labor in order to increase our understanding of mecha-
nisms related to labor pain.
The changes taking place in the extracellular matrix
(ECM) of human corpus and cervix uteri related to the
onset and progress of labor and parturition have been a
focus of interest to our group for many years [2,3]. Ana-
tomically, corpus uteri and cervix constitute one organ but
they function as two different entities. The corpus is dom-
inated by bundles of smooth muscle tissue embedded in
the ECM. In contrast, the cervix is essentially a fibrous
connective tissue organ composed mainly of ECM where
collagen and proteoglycans dominate [3,4]. It remains
closed despite the increasing pressure of the pregnancy,
until final cervical ripening and onset of labor. Ripening
of the cervix is a prerequisite for normal labor and delivery
during which the non-pliable cervix has to soften and
dilate. This implies a dramatic remodeling of the ECM [3].
There are studies on humans showing that cervical ripen-
ing shares features with inflammatory reactions [5,6]. A
number of neuronal and chemical mediators involved in
this process are also known to participate in nociceptive
mechanisms. Nerve fibers containing sensory neuropep-
tides such as substance P (SP) and calcitonin gene related
peptide (CGRP) are present in the human and rodent cer-
vix [7-9]. In addition, biomolecules including prostaglan-
dins, nitric oxide (NO) and cytokines are involved in
painful inflammatory reactions, nociception and cervical
ripening [5,10,11]. The transient receptor potential vanil-
loid receptor subtype 1 (TRPV1, previously known as
VR1) is also a biomolecule associated with inflammatory
conditions and nociception. Therefore, we hypothesized
that TRPV1 is involved in cervical ripening and nocicep-
tive pathways leading to labor pain. The receptor for the
vanilloid capsaicin was first cloned in 1999 [12] and
belongs to the family of transient receptor potential (TRP)
receptors. TRPV1 is expressed particularly by small-diam-
eter sensory neurons, nociceptors. However, it has also
been identified in non-neuronal tissue such as smooth
muscle, polymorphonuclear cells and macrophages
[13,14]. TRPV1 is a cation channel activated by capsaicin,
heat, various lipids and endogenous hydrogen ions
released in tissues during inflammation and is regarded as
a key molecule in peripheral nociception [15-17]. The aim
of this study was to investigate the presence and distribu-
tion of TRPV1 in human corpus and cervix uteri during
late pregnancy and labor, using immunohistochemical
methods and biopsies from non-pregnant subjects as con-
trols.
Methods
Patients
Three different groups of patients were studied. One
group consisted of eight non-pregnant (NP) women who
underwent a hysterectomy because of menorraghia due to
myoma. They were all menstruating regularly and none
received any hormonal therapy. Biopsies were obtained
between cycle day 6 and 24 (six subjects between cycle day
6–14, one on cycle day 24 and two unknown). A second
group comprised eight term pregnant (TP) women with
normal pregnancy and who had elective caesarean section
(CS) prior to onset of labor for one or more of the follow-
ing reasons: fetal breech position, repeated CS, CS on
demand, or vaginal fistula. The third group consisted of
eight term pregnant women in established spontaneous
labor (TPL). These all had emergency CS due to arrest of
labor, fetal malpresentation or fetal distress. Clinical char-
acteristics are given in Table 1. All patients gave their
informed, written consent. The Local Ethics Committee of
the Karolinska University Hospital approved the study,
Table 1: Clinical characteristics of patients
Non-pregnant n = 8 Term-pregnant n = 8 In labor n = 8
Mean age (years) 43 36 31
Range 39–50 29–42 27–35
Mean gestational age Completed weeks 38 40
Range 37–39 39–41
Mean parity 22 2
Range 1–4 1–4 1–2
Mean cervical dilatation (cm) 7
Range 4–10
Mean birth weight (g) 3329 4060
Range 2700–4005 3295–5370Reproductive Biology and Endocrinology 2008, 6:8 http://www.rbej.com/content/6/1/8
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which was conducted according to the Declaration of Hel-
sinki.
Sampling procedures
Biopsies (400–500 mg) were taken from the isthmic part
of the corpus uteri, from now on referred to as corpus.
Thus, they were excised from the upper edge of the lower
uterine segment where the incision was made during CS.
The abdominal serosa and decidua were removed. Biop-
sies from the corresponding area in the non-pregnant
uterus were obtained after hysterectomy. Cervical biopsies
(150–300 mg) were taken transvaginally from the ante-
rior cervical lip, including all layers, at the 12 o'clock posi-
tion, after CS or hysterectomy. All tissues were snap frozen
on dry ice and stored at -70°C until use.
Tissues
Specimens were obtained from the cervix and corpus of
the uterus from 3 groups of women: non-pregnant (n = 8),
term pregnant before onset of labor (n = 8) and term preg-
nant in labor (n = 8).
Antibodies
Primary antibodies used in this study are listed in Table 2.
In order to maximize detection of sensory fibers in sec-
tions from frozen tissues, the antibodies to the light
(peripherin) and heavy subunits of neurofilaments
(NFILS) were combined and used as a "cocktail" [18],
since peripherin and NFILS antibodies label distinct sub-
populations of sensory neurons in dorsal root ganglia.
Immunohistology
Frozen tissue sections (15 µm) were placed on poly-L-
lysine-coated (Sigma, Poole, Dorset, UK) glass slides. The
tissue sections were thereafter fixed in 4% w/v paraformal-
dehyde. Endogenous peroxidase was blocked by incuba-
tion in 0.3% w/v hydrogen peroxide in industrial
methylated spirit (IMS). After rehydration in phosphate-
buffered saline (PBS), sections were incubated overnight
with primary antibodies (Table 2). Sites of antibody
attachment were revealed using nickel-enhanced, immu-
noperoxidase method (avidin-biotin complex – ABC elite;
Vector Laboratories, High Wycombe, Bucks. U.K.). Nega-
tive controls included the omission of primary antibodies
or their replacement with non-immune serum. The specif-
icity of TRPV1 antibodies has been described previously
[19]. Nuclei were counterstained with 0.1% w/v aqueous
neutral red.
For the analysis of NFILS and TRPV1 in the sub-epithe-
lium, positive fibers were counted along the length of the
sections in the sub-epithelial area extending 200 microns
below the basal lamina. It should be noted that this
method will not measure nerve fibers from separate, dis-
tinct neurons since fiber profiles may pass in and out of
the plane of the sections. Sections were counted by two
blinded observers, and results expressed as number of fib-
ers per mm2. The intensity of immunostaining of nerve
fibers appeared uniform and no attempt was made to
measure this since any small variations would be of little
value. Since TRPV1-immunoreactive (IR) fibers appeared
to be very few throughout the rest of the stroma their fre-
quency was assessed by counting all IR nerve fiber profiles
in the entire tissue section (including the sub-epithelial
region) from each sample and the total area of the section
was measured using a microscope eyepiece graticule.
NFILS-IR fibers were much more frequent. They were
assessed by counting NFILS-IR nerve fiber profiles in four
microscope fields at ×20 objective magnification and
these values were compared between groups.
Statistical analysis
Data were analyzed using Kruskal-Wallis ANOVA by
Ranks, Kruskal-Wallis test, p < 0.05 indicated significance.
Results
Cervix: TRPV1
Medium to fine caliber TRPV1-IR fibers (Fig. 1a) were
detected in all samples, as single fibers or groups of fibers
within nerve fascicles scattered throughout the stroma
(Fig. 1b) and around blood vessels (Fig. 1c). Comparison
of TRPV1-IR nerves between the groups did not show sig-
nificantly different values (Fig. 1e, 1f).
Corpus: TRPV1
TRPV1-IR fibers were present within nerve fascicles in con-
trols (Fig. 1d). However, in the TP group, almost all vision
fields lacked TRPV1-positive fibers. No TRPV1-IR whatso-
Table 2: Primary Antibodies
Antibody Host Source:Ref Titer
TRPV1 Rabbit GlaxoSmithKline, Harlow Essex UK: C22 1:10,000
Neurofilament Phosphorylated and non-
phosphorylated 200 kDa subunit
Mouse Dako Cytomation, Ely, UK: Clone N52 1:100,000
Neurofilament Phosphorylated 200 kDa and 
70 kDa subunits
Mouse Dako Cytomation, Ely, UK: Clone 2F11 1:10,000
Peripherin Mouse Novacastra, Newcastle upon Tyne, UK: Clone PJM50 1:500Reproductive Biology and Endocrinology 2008, 6:8 http://www.rbej.com/content/6/1/8
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Photomicrographs showing TRPV1-IR nerve fibers in TP cervix (a-c) and a TRPV1-IR nerve fascicle in NP corpus (d) Figure 1
Photomicrographs showing TRPV1-IR nerve fibers in TP cervix (a-c) and a TRPV1-IR nerve fascicle in NP corpus (d). Box plots 
show the distribution of cervical TRPV1-IR nerve fibers. TRPV1-IR nerve fibers were observed subepithelially (a, arrows) and 
in the stroma (b, arrow) as well as around blood vessels (c, arrows). Scale bars = 50 µm. TRPV1-IR nerve fibers did not differ 
significantly between the groups either when presented as total count of positive nerve fibers (e) or as TRPV1 positive nerve 
fibers/mm2 (f)Reproductive Biology and Endocrinology 2008, 6:8 http://www.rbej.com/content/6/1/8
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ever was seen in specimens taken after onset of labor. This
very low frequency precluded statistical analysis.
Cervix: Neurofilament
NFILS-IR fibers were scattered throughout the stroma with
only rare fibers penetrating the basal epithelium (Fig. 2a).
Counts of IR-nerve fibers in entire sections revealed values
which were not significantly different between the groups
(Fig. 2e).
Corpus: Neurofilament
NFILS-IR nerve fibers and fascicles were detected through-
out all of the control non-pregnant samples (Fig. 2b), but
were much fewer in samples taken at term and labor.
There was a significant decrease of NFILS-IR fibers per
mm2 in term pregnant specimens compared to controls p
< 0.0001, and specimens in labor versus controls p < 0.01
(Fig. 2c). The total count of NFILS-IR nerve fibers also dif-
fered significantly (Fig. 2d). There was a significant
decrease of total NFILS-IR nerve fibers in term pregnancy
compared to the non-pregnant state, p < 0.001 (Fig 2d)
and in labor compared to controls, p < 0.05. However, the
differences between TP and TPL did not reach significance
(Fig. 2c, 2d).
Discussion
To the best of our knowledge, this study provides the first
immunohistochemical evidence for the presence of
TRPV1-IR nerve fibers in the human corpus and cervix
uteri in the pregnant state and labor. TRPV1-IR fibers dis-
appear almost completely in the pregnant corpus, whilst
being retained in the cervix throughout pregnancy and
labor.
Changes in uterine innervation are well documented
showing a profound decrease of nerve fibers in the preg-
nant corpus, but a preserved innervation of the cervix [20-
22]. The exact reason for this decrease of nerve fibers in
the pregnant corpus is not known and still under debate.
Both adrenergic and cholinergic nerves appear to be
affected [21]. In this study, we used an "NFILS-cocktail" of
antibodies as a structural nerve marker in serial sections
with TRPV1, since the these antibodies require frozen,
post-fixed sections for optimal immunostaining, whereas
antibodies to S-100 and the general nerve marker PGP9.5
require immersion fixation for optimal results. However,
the results are similar to our previous findings using
PGP9.5 antibodies as structural marker [22].
The disparity in innervation of the corpus and the cervix
in late pregnancy and labor may possibly reflect the differ-
ent functions of the corpus and the cervix at the time
around parturition.
It is well documented that cervical ripening is an inflam-
matory process associated with a 10–100 fold increase of
cytokines and an influx of cells e.g. leukocytes locally in
the cervical tissue [5,6]. Furthermore prostaglandins
[23,24], nitric oxide [10], bradykinin [25] are present as
well as nerve fibers containing SP and CGRP [7,9]. These
biomolecules are also involved in inflammatory induced
pain mechanisms. TRPV1 has been documented to be
associated with these mediators. Previous studies have
shown an up-regulation of cytokines in gastroesophageal
reflux disease [26] and an increase of TRPV1-IR nerve fib-
ers in similar diseases such as non-erosive reflux disease
and inflamed human oesophagus [27,28]. It is reported
that TRPV1 can trigger release of the neuropeptides SP and
CGRP from peripheral terminals in inflamed tissues [15].
Bradykinin, an algogenic substance, can increase TRPV1
sensitivity via pathways dependent on protein kinase C or
phospholipase C [29-31]. Prostaglandins are suggested to
reduce the temperature threshold required for TRPV1 acti-
vation [30]. TRPV1 is activated by various ligand-like
agents through seemingly unrelated stimuli [30,32].
These observations reveal that TRPV1 is a molecular inte-
grator in inflammatory conditions with a complex multi-
functional role [30].
Nerve growth factor (NGF) is another mediator that plays
a pivotal role in inflammation and nociception in periph-
eral tissues. It has a crucial function in the regulation, sur-
vival, maintenance and specification of sensory neurons
[33,34] and is involved in nociceptive pathways [29,35].
Previous studies have shown a significant increase of
TRPV1-IR nerve fibers in inflammatory conditions that
elicit pain, such as painful bladder syndrome [18] and
vulvodynia [17], and are believed to involve NGF. We
have, in an earlier study, demonstrated the occurrence of
the NGF receptor p75 in human corpus and cervix uteri in
pregnancy and labor [36] and have unpublished data
showing mRNA expression for NGFβ and its specific
receptor Trk A in biopsies from human corpus and cervix
uteri in term pregnancy and labor. Studies in other labo-
ratories have also established links between NGF and
TRPV1 where increased TRPV1 levels in peripheral nocic-
eptor terminals are generally restricted to TrkA bearing ter-
minals in inflamed tissue due to NGF mediated activation
of p38 MAPK system [13,29,35,37].
Conclusion
Our results indicate that TRPV1 may be involved in the
final remodeling of ECM in the human cervix in preg-
nancy. This is supported by evidence of interaction with
inflammatory mediators. TRPV1-IR nerve fibers persist in
the cervix during ripening and labor in contrast to their
disappearance in the corpus. This observation suggests
that TRPV1, a key molecule in nociception, is involved in
the mechanisms underlying labor pain. Our findings indi-Reproductive Biology and Endocrinology 2008, 6:8 http://www.rbej.com/content/6/1/8
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Photomicrographs showing NFILS-IR nerve fibers in TPL cervix (a) and a NFILS-IR nerve fascicle in NP corpus (b) Figure 2
Photomicrographs showing NFILS-IR nerve fibers in TPL cervix (a) and a NFILS-IR nerve fascicle in NP corpus (b). Box plots 
show the distribution of NFILS-IR nerve fibers in corpus and cervix uteri. NFILS positive fibers were seen in the stroma and in 
the subepithelial region (a, short arrows). Nerve fibers penetrating the basal epithelium were observed, but only rarely (a, long 
arrow). A NFILS-IR nerve fascicle is seen in control, non-pregnant corpus (b). Scale bars = 50 µm. The box plot in (c) shows 
the distribution of NFILS-IR nerve fibers in the three groups of the corpus counted as nerve fibers/mm2. There is a significant 
decrease of IR-nerve fibres/mm2 in the term pregnant group compared to non-pregnant controls, p < 0.0001. A statistically sig-
nificant decrease of IR-nerve fibers/mm2 is also observed in labor compared to the non-pregnant group, p < 0.01. There is no 
significant difference between TP and TPL. Comparison of NFILS-IR nerve fibers between the "corpus groups" presented as 
total count of positive nerves also shows significantly different values (d). There is a statistically significant decrease in the 
occurrence of IR nerve fibers in the term pregnant compared to the non-pregnant corpus, p < 0.001, and between the non-
pregnant group compared to the term pregnant in labor, p < 0.05. However, there is no significant difference between the two 
pregnant groups. The box plot in (e) shows and compares the distribution of NFILS-IR nerve fibers in the cervical groups. Val-
ues did not reach statistical significance.Reproductive Biology and Endocrinology 2008, 6:8 http://www.rbej.com/content/6/1/8
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cate the cervix to be an important focus for labor pain.
However, further investigations are needed to elucidate
the role of TRPV1 in obstetrical pain.
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